Search results
Results from the WOW.Com Content Network
Pharmacy retailer CVS Health Inc. (NYSE:CVS) is scheduled to report its fourth quarter 2024 earnings on Wednesday, February 12. Wall Street estimates fourth-quarter adjusted EPS of $0.94 and sales ...
On Wednesday, CVS Health Corp (NYSE:CVS) reported fourth-quarter sales of $97.71 billion, beating the consensus of $97.19 billion. Total revenues increased 4.2%, driven by growth in the Health ...
That momentum helped fuel a record quarter for pharmacy sales during which CVS filled 432 million subscriptions, up 9% from Q3 2023, increasing its market share of scripts filled nationally to 27.3%.
CVS (CVS) reported fourth quarter and full-year 2024 earnings Wednesday, beating Wall Street's expectations and sending its stock up 15% for the day. Full-year revenue came in at $372.8 billion ...
CVS is the top U.S. pharmacy in terms of prescription drug revenue, holding more than 25% of the market share in 2023, according to Statista data released in March. Walgreens trailed behind with ...
Shares of CVS Health (NYSE: CVS) were soaring Wednesday after the diversified healthcare giant's fourth-quarter results topped estimates and management offered better-than-expected guidance for 2025.
Image source: The Motley Fool. CVS Health (NYSE: CVS) Q3 2024 Earnings Call Nov 06, 2024, 8:00 a.m. ET. Contents: Prepared Remarks. Questions and Answers. Call ...
CVS Health (CVS) closed the most recent trading day at $63.47, moving +0.06% from the previous trading session.